Clinical Trials Directory

Trials / Completed

CompletedNCT05374369

Retrospective Analysis of Colorectal Cancer Screening Results

Retrospective Analysis of Colorectal Cancer Screening Results Among People Aged 40-74 in Shipai Town, Dongguan City, China

Status
Completed
Phase
Study type
Observational
Enrollment
822 (actual)
Sponsor
Creative Biosciences (Guangzhou) Co., Ltd. · Industry
Sex
All
Age
40 Years – 74 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to retrospectively analyze colorectal cancer screening data of 40-74 year old population in Shipai Town, Dongguan City. In this study, the data of SDC2 Gene Methylation Test and Fecal Immunochemistry Test (Q-FIT) were screened from about 11,000 subjects who participated in Colorectal Cancer Screening in Shipai Town People's Livelihood Project from May 2021 to May 2022. Data from 822 subjects with positive SDC2 Gene Methylation Test and/or positive Fecal Immunochemistry Test (Q-FIT) results and with colonoscopy and/or pathological results were selected for retrospective analysis. This retrospective study evaluated the screening performance of SDC2 Gene Methylation Test and/or Fecal Immunochemistry Test (Q-FIT) for colorectal cancer using colonoscopy and/or pathological results as the clinical standard method.

Detailed description

This study is a retrospective and observational study. Subjects were not be given or offered any treatment during the study. The investigator reviewed the patient's medical history and examination report to determine eligibility based on inclusion and exclusion criteria. This study retrospectively analyse the basic information and the test results of SDC2 Gene Methylation Test and Fecal Immunochemistry Test (Q-FIT) of about 11,000 subjects who participated in the Colorectal Cancer Screening in Shipai Town People's Livelihood Project from May 2021 to May 2022. A total of 822 subjects with positive SDC2 Gene Methylation Test results and / or positive Fecal Immunochemistry Test (Q-FIT) results were screened out and their colonoscopy results were collected. 822 subjects were classified according to colonoscopy and/or pathological detection results, and the screening performance of the SDC2 Gene Methylation Test and Fecal Immunochemistry Test (Q-FIT) for colorectal cancer was statistically analyzed.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSDC2 Gene Methylation Test and Q-FIT TestStool specimens were collected by the subjects for SDC2 Gene Methylation Test and Q-FIT Test
PROCEDUREColonoscopy and/or pathological examinationSubjects underwent colonoscopy and/or pathological examination.

Timeline

Start date
2022-03-29
Primary completion
2022-04-28
Completion
2022-04-28
First posted
2022-05-16
Last updated
2022-07-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05374369. Inclusion in this directory is not an endorsement.